Yamaguchi et al. found that expression of FGFR1 increases with WHO grade in astrocytomas [39], and increased FGFR1 levels in GBM are not due to amplification of the FGFR1 gene [83]. The gene discussed is FGFR1; the disease is astrocytoma (excluding glioblastoma).